Clinical trial Recruiting at 1 site Interventional Ages 45 to 70

Immersive virtual reality training to improve thinking and memory in adults with metabolic syndrome

Official title: Multimodal Immersive Virtual Reality Training for Improving Cognition in Adults With Metabolic Syndrome: A Randomized Clinical Trial

Run by Consorci Sanitari de Terrassa · NCT07040748 · Data updated 2026-11-12

This project will try immersive virtual reality sessions that combine cognitive exercises and physical activity to see if they improve thinking and memory in middle-aged adults with metabolic syndrome who report cognitive complaints.

Quick facts

Study typeInterventional
Ages45 Years to 70 Years
SexAll
Enrollment84 (estimated)
SponsorConsorci Sanitari de Terrassa
Academic / other
Locations1 site (Terrassa)
StatusRecruiting
StartedMarch 1, 2025
Main results expectedApril 1, 2027
Study endsApril 1, 2027
Registry record updatedOctober 23, 2026
Trial IDNCT07040748 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are Spanish- or Catalan-speaking adults aged 45–70 who meet metabolic syndrome criteria and report subjective cognitive complaints.

Probably not a fit

People with suspected dementia, significant psychiatric or neurological disorders, major systemic illnesses, or who cannot attend in-person sessions or speak Spanish/Catalan are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, single-blind trial will enroll 84 adults aged 45–70 with metabolic syndrome and subjective cognitive complaints and assign them to either the Virtual-METS program or treatment-as-usual. The Virtual-METS program delivers group immersive virtual reality sessions combining cognitive training and physical exercise twice weekly for 12 weeks (24 sessions total). Primary outcomes are cognitive performance measured by a neuropsychological battery and eye-tracking tasks, with secondary outcomes of treatment adherence, daily functioning, and quality of life assessed at baseline, post-treatment, and six months. Ophthalmologic exams, carotid Doppler ultrasound, and panels of blood-based and gut-derived biomarkers will also be collected to explore physiological mechanisms.

Why it matters

Potential benefit: If successful, this non-drug program could improve cognitive function and daily functioning in people with metabolic syndrome while offering a more engaging and accessible therapy.

How similar studies have gone: Previous small trials and multimodal exercise-plus-cognitive programs have shown promising but mixed effects on cognition, and immersive VR approaches are emerging with encouraging early results but limited large-scale evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Demonstrated criteria for the MetS: central obesity (waist circumference ≥ 94 cm for men or ≥ 80 cm for women) and at least 2 of the criteria described as follow: Triglycerides ≥ 150 mg/dl or specific treatment of this lipid disorder; HDL-C \< 40 mg/dl (men) or \< 50 mg/dl (women) or specific treatment of this lipid disorder; Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg or previously diagnosed hypertension treatment; Basal glycemia ≥ 100 mg/dl or type 2 diabetes previously diagnosed).
* Age: between 45 and 70 years old.
* Subjective cognitive complaints: Subjective Cognitive Decline Questionnaire (≥ 7).
* Ability to fully understand and speak Spanish or Catalan.

Exclusion Criteria:

* Confirmed or suspicion of dementia (MMSE\<24).
* Diagnosis of severe psychiatric, neurological, developmental disorders, systemic pathologies, hematological, hormonal, nutritional pathology, and/or neoplasm that are known to cause cognitive deficits.
* Other severe comorbidities considered a probable bias for the study: a cardiac history of unstable angina, recent myocardial infarction within the last 3 months, congestive heart failure, significant heart valve dysfunction, or unstable hypertension; taking medications that could negatively affect cognitive function.
* Physical, motor, or sensory alterations that impede the neuropsychological examination or the rehabilitation program.

Where it's running

  • Consorci Sanitari de Terrassa
    Terrassa, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.